AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response.

Schuiveling M, van Duin IAJ, Ter Maat LS, van der Weerd JC, Verheijden RJ, van den Berkmortel F, Blank CU, Breimer GE, Burgers FH, Boers-Sonderen M, Labots M, de Groot JWB, Haanen JBAG, Hospers GAP, Kapiteijn E, Piersma D, Simkens L, Westgeest HM, Schrader AMR, Pluim JPW, van Diest PJ, Blokx WAM, Veta M, Suijkerbuijk KPM

Open source

DOI: 10.1016/j.ejca.2026.116831
Published: 2026 Jun 25
Container: European journal of cancer (Oxford, England : 1990)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2026.116831,
  title = {AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response.},
  author = {Schuiveling M and van Duin IAJ and Ter Maat LS and van der Weerd JC and Verheijden RJ and van den Berkmortel F and Blank CU and Breimer GE and Burgers FH and Boers-Sonderen M and Labots M and de Groot JWB and Haanen JBAG and Hospers GAP and Kapiteijn E and Piersma D and Simkens L and Westgeest HM and Schrader AMR and Pluim JPW and van Diest PJ and Blokx WAM and Veta M and Suijkerbuijk KPM},
  year = {2026},
  journal = {European journal of cancer (Oxford, England : 1990)},
  doi = {10.1016/j.ejca.2026.116831},
  url = {https://doi.org/10.1016/j.ejca.2026.116831}
}

RIS

TY  - JOUR
TI  - AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response.
AU  - Schuiveling M
AU  - van Duin IAJ
AU  - Ter Maat LS
AU  - van der Weerd JC
AU  - Verheijden RJ
AU  - van den Berkmortel F
AU  - Blank CU
AU  - Breimer GE
AU  - Burgers FH
AU  - Boers-Sonderen M
AU  - Labots M
AU  - de Groot JWB
AU  - Haanen JBAG
AU  - Hospers GAP
AU  - Kapiteijn E
AU  - Piersma D
AU  - Simkens L
AU  - Westgeest HM
AU  - Schrader AMR
AU  - Pluim JPW
AU  - van Diest PJ
AU  - Blokx WAM
AU  - Veta M
AU  - Suijkerbuijk KPM
PY  - 2026
JO  - European journal of cancer (Oxford, England : 1990)
DO  - 10.1016/j.ejca.2026.116831
UR  - https://doi.org/10.1016/j.ejca.2026.116831
ER  -

APA

M, S., IAJ, V. D., LS, T. M., JC, V. D. W., RJ, V., F, V. D. B., CU, B., GE, B., FH, B., M, B., M, L., JWB, D. G., JBAG, H., GAP, H., E, K., D, P., L, S., HM, W., AMR, S., JPW, P., PJ, V. D., WAM, B., M, V., & KPM, S. (2026). AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2026.116831

Source records

pubmed · retrieved 2026-09-24T23:28:24.043Z